Literature DB >> 18951874

Oxidative stress modulates theophylline effects on steroid responsiveness.

John A Marwick1, Gillian Wallis, Koremu Meja, Bernhard Kuster, Tewis Bouwmeester, Probir Chakravarty, Danielle Fletcher, Paul A Whittaker, Peter J Barnes, Kazuhiro Ito, Ian M Adcock, Paul A Kirkham.   

Abstract

Oxidative stress is a central factor in many chronic inflammatory diseases such as severe asthma and chronic obstructive pulmonary disease (COPD). Oxidative stress reduces the anti-inflammatory corticosteroid action and may therefore contribute to the relative corticosteroid insensitivity seen in these diseases. Low concentrations of theophylline can restore the anti-inflammatory action of corticosteroids in oxidant exposed cells, however the mechanism remains unknown. Here, we demonstrate that a low concentration of theophylline restores corticosteroid repression of pro-inflammatory mediator release and histone acetylation in oxidant exposed cells. Global gene expression analysis shows that theophylline regulates distinct pathways in naïve and oxidant exposed cells and reverses oxidant mediated modulated of pathways. Furthermore, quantitative chemoproteomics revealed that theophylline has few high affinity targets in naive cells but an elevated affinity in oxidant stressed cells. In conclusion, oxidative stress alters theophylline binding profile and gene expression which may result in restoration of corticosteroid function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18951874     DOI: 10.1016/j.bbrc.2008.10.065

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  Epidemiology of stress and asthma: from constricting communities and fragile families to epigenetics.

Authors:  Rosalind J Wright
Journal:  Immunol Allergy Clin North Am       Date:  2011-02       Impact factor: 3.479

Review 2.  Overcoming reduced glucocorticoid sensitivity in airway disease: molecular mechanisms and therapeutic approaches.

Authors:  John A Marwick; Ian M Adcock; Kian Fan Chung
Journal:  Drugs       Date:  2010-05-28       Impact factor: 9.546

Review 3.  Perinatal stress and early life programming of lung structure and function.

Authors:  Rosalind J Wright
Journal:  Biol Psychol       Date:  2010-01-18       Impact factor: 3.251

4.  Stress and acquired glucocorticoid resistance: a relationship hanging in the balance.

Authors:  Rosalind J Wright
Journal:  J Allergy Clin Immunol       Date:  2009-04       Impact factor: 10.793

Review 5.  Current perspectives on role of chromatin modifications and deacetylases in lung inflammation in COPD.

Authors:  Saravanan Rajendrasozhan; Hongwei Yao; Irfan Rahman
Journal:  COPD       Date:  2009-08       Impact factor: 2.409

6.  Corticosteroid responsiveness and clinical characteristics in childhood difficult asthma.

Authors:  C J Bossley; S Saglani; C Kavanagh; D N R Payne; N Wilson; L Tsartsali; M Rosenthal; I M Balfour-Lynn; A G Nicholson; A Bush
Journal:  Eur Respir J       Date:  2009-06-18       Impact factor: 16.671

7.  Increased FKBP51 in induced sputum cells of chronic obstructive pulmonary disease patients after therapy.

Authors:  A Holownia; R M Mroz; A Kolodziejczyk; E Chyczewska; J J Braszko
Journal:  Eur J Med Res       Date:  2009-12-07       Impact factor: 2.175

Review 8.  Glucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary disease.

Authors:  John A Marwick; Kian Fan Chung
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-09-07

9.  Progress in the management of childhood asthma.

Authors:  Pakit Vichyanond; Rattana Pensrichon; Suruthai Kurasirikul
Journal:  Asia Pac Allergy       Date:  2012-01-31

10.  Phagosomal Acidification Prevents Macrophage Inflammatory Cytokine Production to Malaria, and Dendritic Cells Are the Major Source at the Early Stages of Infection: IMPLICATION FOR MALARIA PROTECTIVE IMMUNITY DEVELOPMENT.

Authors:  Xianzhu Wu; Nagaraj M Gowda; D Channe Gowda
Journal:  J Biol Chem       Date:  2015-08-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.